Literature DB >> 25078727

Rituximab in patients with recalcitrant autoimmune blistering diseases: experience in a cohort of 22 patients.

D Tomsitz1, R Stefaniak, M Worm.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25078727     DOI: 10.1111/bjd.13307

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  3 in total

1.  Pemphigus Foliaceus-Repeated Treatment With Rituximab 7 Years After Initial Response: A Case Report.

Authors:  Magdalena Kraft; Margitta Worm
Journal:  Front Med (Lausanne)       Date:  2018-11-09

2.  Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review.

Authors:  Peng Cao; Wenjing Xu; Litao Zhang
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

Review 3.  Off-Label Uses of Rituximab in Dermatology.

Authors:  Connor Cole; Kyle T Amber
Journal:  Curr Dermatol Rep       Date:  2022-10-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.